The clinical biochemistry of 5'-nucleotidase.
This review delineates the subcellular distribution, biochemical characteristics, and metabolic functions of 5'-nucleotidase (5'NT), summarizes the analytical biochemistry of 5'NT, and assesses the clinical significance of 5'NT determinations in body fluids, cells, and tissues. Salient aspects of the clinical biochemistry of 5'NT, discussed herein, are as follows: (A) Serum 5'NT activity is generally elevated in hepatobiliary diseases, especially with intrahepatic obstruction, but, unlike serum alkaline phosphatase, serum 5'NT activity is not increased in infancy, childhood, pregnancy, or osteoblastic disorders. (B) In cancer patients, elevated serum 5'NT activity does not always indicate hepatobiliary involvement; in some cases, 5'NT may be released into serum from the primary tumor or local metastases. (C) Genetic deficiency of erythrocyte pyrimidine 5'NT activity is a common cause of hereditary non-spherocytic hemolytic anemia. (D) Acquired deficiency of erythrocyte pyrimidine 5'NT activity occurs in patients with beta-thalassemia and lead poisoning. (E) 5'NT activity is low in circulating monocytes, increases markedly upon their differentiation to tissue macrophages, and subsequently diminishes during macrophage activation. (F) Lymphocyte ecto-5'NT activity, a plasma membrane marker of cell maturation, is generally low in immunodeficiency states, and undergoes characteristic changes in patients with certain lymphomas and leukemias.
Sunderman
F W
FW
Department of Laboratory Medicine, University of Connecticut Medical School, Farmington 06032.
D015720:5'-Nucleotidase / Q000378:metabolism*; D000746:Anemia, Hemolytic, Congenital Nonspherocytic / Q000378:metabolism; D006801:Humans; D007855:Lead Poisoning / Q000378:metabolism; D008297:Male; D009369:Neoplasms / Q000097:blood; D011471:Prostatic Neoplasms / Q000378:metabolism; D015032:Zinc / Q000172:deficiency
D015720:5'-Nucleotidase; D015032:Zinc